Inhaled versus systemic steroids in chronic oxygen dependency of preterm infants
- PMID: 9007492
- DOI: 10.1007/s004310050552
Inhaled versus systemic steroids in chronic oxygen dependency of preterm infants
Abstract
The speed of action and side-effects of systemic verus inhaled steroids was compared in infants with mild-moderate oxygen dependency. Forty infants (median gestational age 27 weeks) were randomized to receive either 10 days of dexamethasone (systemic group) or budesonide (100 micrograms qds) (inhaled group). At randomization, there was no significant difference in the gestational or postnatal age, inspired oxygen requirements or compliance of the respiratory system of the two groups. After 36 h of treatment, there were significant changes (P < 0.01) in both the inspired oxygen concentration and compliance of the respiratory system in the systemic but not the inhaled group. Only after 1 week of inhaled therapy were improvements in respiratory status noted but, even at that time, the inspired oxygen requirement was significantly lower in the systemic versus the inhaled group. In the systemic group only, however, were there significant increases in blood pressure.
Conclusion: Systemically administered rather than inhaled steroids appear to have a faster onset of action.
Similar articles
-
A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide.Pediatrics. 2001 Feb;107(2):232-40. doi: 10.1542/peds.107.2.232. Pediatrics. 2001. PMID: 11158452 Clinical Trial.
-
Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.Neonatology. 2015;107(4):358-9. doi: 10.1159/000381132. Epub 2015 Jun 5. Neonatology. 2015. PMID: 26044104 Review.
-
[Glucocorticoide therapy in premature infants: French practices in 2006].Arch Pediatr. 2009 Jul;16(7):999-1004. doi: 10.1016/j.arcped.2009.03.013. Epub 2009 May 1. Arch Pediatr. 2009. PMID: 19410441 French.
-
[Bronchopulmonary dysplasia and corticosteroid therapy].Arch Pediatr. 2002 Feb;9(2):159-68. doi: 10.1016/s0929-693x(01)00726-6. Arch Pediatr. 2002. PMID: 11915499 Review. French.
-
Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia.N Engl J Med. 2015 Oct 15;373(16):1497-506. doi: 10.1056/NEJMoa1501917. N Engl J Med. 2015. PMID: 26465983 Clinical Trial.
Cited by
-
Systematic Review of Inhaled Bronchodilator and Corticosteroid Therapies in Infants with Bronchopulmonary Dysplasia: Implications and Future Directions.PLoS One. 2016 Feb 3;11(2):e0148188. doi: 10.1371/journal.pone.0148188. eCollection 2016. PLoS One. 2016. PMID: 26840339 Free PMC article.
-
Review of the antenatal and postnatal use of steroids.Indian J Pediatr. 2014 May;81(5):466-72. doi: 10.1007/s12098-014-1376-9. Epub 2014 Mar 30. Indian J Pediatr. 2014. PMID: 24682835 Review.
-
Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.Cochrane Database Syst Rev. 2017 Oct 17;10(10):CD002058. doi: 10.1002/14651858.CD002058.pub3. Cochrane Database Syst Rev. 2017. PMID: 29041034 Free PMC article.
-
Airway administration of corticosteroids for prevention of bronchopulmonary dysplasia in premature infants: a meta-analysis with trial sequential analysis.BMC Pulm Med. 2017 Dec 15;17(1):207. doi: 10.1186/s12890-017-0550-z. BMC Pulm Med. 2017. PMID: 29246209 Free PMC article. Review.
-
Post-natal corticosteroid use.Eur J Pediatr. 2003 Sep;162(9):613-5. doi: 10.1007/s00431-003-1273-0. Epub 2003 Jul 16. Eur J Pediatr. 2003. PMID: 12884035
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical